ArticleJACC. Advances2023
Automated Echocardiographic Detection of Heart Failure With Preserved Ejection Fraction Using Artificial Intelligence.
Article in JACC. Advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial Intelligence-Based Echocardiographic Assessment of Diastolic Dysfunction: A Systematic Review.Echocardiography (Mount Kisco, N.Y.) · 2026Pooled it
- The LEDA Score: An Integrated Echocardiographic Score for the Diagnosis of HFpEF.JACC. Advances · 2026Article
- The diagnostic accuracy of left ventricular ejection fraction assessment between visual and artificial intelligence-based algorithms on bedside ultrasound.Cardiovascular ultrasound · 2026Article
- Automated HFrEF Diagnosis Using an Optimized TimeSformer Model in Echocardiography.Journal of imaging informatics in medicine · 2026Article
- Heart Failure with Preserved Ejection Fraction in Women: Sex-Specific Insights Across the Continuum from Diagnosis to Outcomes.Current cardiology reports · 2026Review
- Artificial intelligence in echocardiography: a position statement from the British Society of Echocardiography.Echo research and practice · 2026Review
- Understanding HFpEF Through Imaging: Strengths, Limitations, and Current State of the Art.JACC. Cardiovascular imaging · 2026Review
- Smarter FoCUS: AI-guided focused cardiac ultrasound enables novice detection of left ventricular dysfunction.European heart journal. Digital health · 2026Article
- Deep learning-derived pericardial adipose tissue by electrocardiogram-gated cardiac computed tomography predicts cardiovascular events beyond coronary calcium score.American journal of preventive cardiology · 2026Article
- Machine learning-based stratification of chagas heart failure severity using ECG power spectral biomarkers.Medical & biological engineering & computing · 2026Article
- Artificial Intelligence in Heart Failure with Preserved Ejection Fraction.Diagnostics (Basel, Switzerland) · 2026Review
- The Evolving Utility of Artificial Intelligence-Based Tools for the Detection of Heart Failure and Cardiomyopathies: From Potential to Implementation.Current heart failure reports · 2026Review
- Artificial intelligence in echocardiography: Applications and future directions.Fundamental research · 2026Review
- Artificial intelligence in cardiology in the current era: a narrative review.Cardiovascular diagnosis and therapy · 2026Review
- Reproducibility of echocardiographic measurements of left ventricular systolic function: a systematic review and meta-analysis comparing artificial intelligence and clinician estimates.European heart journal. Digital health · 2026Review
- Revolutionizing Heart Failure Management With Artificial Intelligence: A Narrative Review of Diagnostic, Prognostic, and Therapeutic Innovations.Health science reports · 2026Article
- Clinical Applications of Artificial Intelligence in Cardiovascular Imaging: Where Do We Stand?Life (Basel, Switzerland) · 2026Review
- Precision cardiovascular medicine with big data and AI.NPJ digital medicine · 2026Review
- Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis.Chinese medical journal · 2026Review
- Invasive haemodynamic validation of an artificial intelligence echocardiographic tool for detecting heart failure with preserved ejection fraction.ESC heart failure · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Detection of heart failure with preserved ejection fraction (HFpEF) involves integration of multiple imaging and clinical features which are often discordant or indeterminate. Objectives: The authors applied artificial intelligence (AI) to analyze a single apical 4-chamber transthoracic echocardiogram video clip to detect HFpEF. Methods: A 3-dimensional convolutional neural network was developed and trained on apical 4-chamber video clips to classify patients with HFpEF (diagnosis of heart failure, ejection fraction ≥50%, and echocardiographic evidence of increased filling pressure; cases) vs without HFpEF (ejection fraction ≥50%, no diagnosis of heart failure, normal filling pressure; controls). Model outputs were classified as HFpEF, no HFpEF, or nondiagnostic (high uncertainty). Performance was assessed in an independent multisite data set and compared to previously validated clinical scores. Results: Training and validation included 2,971 cases and 3,785 controls (validation holdout, 16.8% patients), and demonstrated excellent discrimination (area under receiver-operating characteristic curve: 0.97 [95% CI: 0.96-0.97] and 0.95 [95% CI: 0.93-0.96] in training and validation, respectively). In independent testing (646 cases, 638 controls), 94 (7.3%) were nondiagnostic; sensitivity (87.8%; 95% CI: 84.5%-90.9%) and specificity (81.9%; 95% CI: 78.2%-85.6%) were maintained in clinically relevant subgroups, with high repeatability and reproducibility. Of 701 and 776 indeterminate outputs from the Heart Failure Association-Pretest Assessment, Echocardiographic and Natriuretic Peptide Score, Functional Testing (HFA-PEFF), and Final Etiology and Heavy, Hypertensive, Atrial Fibrillation, Pulmonary Hypertension, Elder, and Filling Pressure (H2FPEF) scores, the AI HFpEF model correctly reclassified 73.5% and 73.6%, respectively. During follow-up (median: 2.3 [IQR: 0.5-5.6] years), 444 (34.6%) patients died; mortality was higher in patients classified as HFpEF by AI (HR: 1.9 [95% CI: 1.5-2.4]). Conclusions: An AI HFpEF model based on a single, routinely acquired echocardiographic video demonstrated excellent discrimination of patients with vs without HFpEF, more often than clinical scores, and identified patients with higher mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.